Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Clinical trial NCT01598051 · COMPLETED

Trial details

NCT number: NCT01598051
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Non-valvular Atrial Fibrillation (NVAF)

Start date: 2012-05-31
Primary completion: 2016-06-09
Enrollment: 741

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.